Update: NCCN colon and rectal cancer clinical practice guidelines

J Natl Compr Canc Netw. 2004 Sep:2 Suppl 3:S-14-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bevacizumab
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Chemoradiotherapy
  • Colonic Neoplasms / drug therapy*
  • Fluorouracil / administration & dosage
  • Humans
  • Leucovorin / administration & dosage
  • Organoplatinum Compounds / administration & dosage
  • Practice Guidelines as Topic
  • Radiotherapy, Adjuvant
  • Rectal Neoplasms / drug therapy*
  • Rectal Neoplasms / radiotherapy*
  • Rectal Neoplasms / surgery

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Organoplatinum Compounds
  • Bevacizumab
  • Leucovorin
  • Fluorouracil
  • Camptothecin

Supplementary concepts

  • Folfox protocol
  • IFL protocol